AMID Co., April 2009, Pages: 188
Chinese Markets for HypertensionDrugsChinas demand for HypertensionDrugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow
Draco Healthcare Consulting LLC, Nov 2011 ChinaHypertension Prescription Drug Sales Data 2007-2010 The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different
ICON Group International, Jan 2011, Pages: 142
The 2011-2016 Outlook for Anti-HypertensiveDrugs in Greater China WHAT IS LATENT DEMAND AND THE P.I.E.?
The concept of latent demand is rather subtle. The term latent typically refers to something
BioPharm Reports (VennBio Ltd.), Nov 2009, Pages: 225
, Biopharm Reports has conducted a global survey on current treatments and drug prescribing practices for Hypertension. This survey involved the participation of more than 280 clinical centres in 50 countries
BioPharm Reports (VennBio Ltd.), June 2010, Pages: 225
, Biopharm Reports has conducted a global survey on current treatments and drug prescribing practices for Hypertension. This survey involved the participation of more than 280 clinical centres in 50 countries
John Wiley and Sons Ltd, April 2009, Pages: 416
Handbook of Hypertension When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy
Global Industry Analysts, Inc., Feb 2010, Pages: 893
Ranbaxy Receives Approval to Market Anti-HypertensionDrug II-32
Actelion Receives FDA Approval for New Ventavis Formulation II-32
Sinobiopharma Receives Chinese Approval for Perindopril II-32
Pfizer
Draco Healthcare Consulting LLC, Nov 2011
systemically. The comprehensive prescription data in China will present you a clear picture of the competition landscape of Chinesedrug market for each therapeutic area (such as cancer, hypertension, diabetes
Draco Healthcare Consulting LLC, Nov 2011
systemically. The comprehensive prescription data in China will present you a clear picture of the competition landscape of Chinesedrug market for each therapeutic area (such as cancer, hypertension, diabetes
Draco Healthcare Consulting LLC, Nov 2011
, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market.
This series
Draco Healthcare Consulting LLC, Nov 2011
, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market.
This series
Draco Healthcare Consulting LLC, Nov 2011
systemically. The comprehensive prescription data in China will present you a clear picture of the competition landscape of Chinesedrug market for each therapeutic area (such as cancer, hypertension, diabetes
Draco Healthcare Consulting LLC, Nov 2011
systemically. The comprehensive prescription data in China will present you a clear picture of the competition landscape of Chinesedrug market for each therapeutic area (such as cancer, hypertension, diabetes
Draco Healthcare Consulting LLC, Nov 2011
, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market.
This series
Draco Healthcare Consulting LLC, Nov 2011
, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market.
This series
Draco Healthcare Consulting LLC, Nov 2011
systemically. The comprehensive prescription data in China will present you a clear picture of the competition landscape of Chinesedrug market for each therapeutic area (such as cancer, hypertension, diabetes
GlobalData, March 2012, Pages: 279
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment
Draco Healthcare Consulting LLC, Dec 2011
, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market.
This series
Draco Healthcare Consulting LLC, Nov 2011
, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market.
This series
Draco Healthcare Consulting LLC, Nov 2011
, hypertension, diabetes, to name a few) and the market potential for your company's product(s) that already marketed in China or if you are planning to bring your drugs to the China market.
This series